RecruitingNot ApplicableNCT05797519
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
Sponsor
VDyne, Inc.
Enrollment
120 participants
Start Date
Mar 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this clinical study is to collect safety and efficacy data of the VDyne System to support Conformitè Europëenne (CE) Mark of the VDyne System.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called VDyne Transcatheter Tricuspid Valve Replacement System for people with tricuspid regurgitation, tricuspid valve disease, and other related conditions. The study is currently recruiting participants at 21 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEVDyne Transcatheter Tricuspid Valve Replacement System
The study investigational device is the VDyne Transcatheter Tricuspid Valve Replacement System.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05797519
Related Trials
Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation
NCT070423601 location
Transcatheter Tricuspid Valve Replacement Using the Lux-Valve Plus System
NCT06714500
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
NCT0603327421 locations
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NCT0409714579 locations
3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device
NCT07793916